ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.

Features

Auto Apply Resume Optimizer Cover Letter Optimizer Interview Prep

Company

Social Media

Need Help?

team@applyblast.com

Associate Director, Biomarker Analysis at Crinetics Pharmaceuticals - ApplyBlast

Associate Director, Biomarker Analysis

Crinetics Pharmaceuticals

4 months ago

3.2 on Glassdoor

Hybrid

Full Time

Senior

0 applicants

View Job Listing

Apply to 100+ jobs

About this role

The Associate Director of Biomarker Bioanalysis at Crinetics manages outsourced bioanalysis and biomarker activities, overseeing platform selection, development, and validation for nonclinical and clinical trials. This role involves leading regulatory submissions, auditing CROs, and collaborating with cross-functional teams to advance small molecule therapeutics for endocrine disorders. The position sits within a small, well-funded drug discovery company in San Diego with a patient-centric culture.

Responsibilities

Manage outsourced bioanalysis CROs and CLIA clinical testing labs
Develop strategic biomarker analysis plans for drug candidates
Lead preparation of bioanalytical content for regulatory submissions
Audit bioanalytical vendors to ensure accreditation compliance
Negotiate scopes of work and manage assay budgets

Skills

Qualifications

Bachelor's degree in relevant scientific field10+ years of industry experience7+ years in supervisory role

About Crinetics Pharmaceuticals

crinetics.com

Headquarters

San Diego, California, United States

Company Size

201-500 employees

Founded

2008

View Profile

Crinetics Pharmaceuticals, now a Vertex Pharmaceuticals company, is a pharmaceutical company dedicated to discovering, developing, and commercializing treatments for endocrine diseases. Based in San Diego, CA, the company maintains a pipeline of novel therapies including Paltusotine (an oral SST2 agonist) and Atumelnant (an oral ACTH antagonist). Crinetics aims to be the premier endocrine-rooted global pharmaceutical company, focused on improving the lives of patients with endocrine disorders.